Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 22% ± 7% | |
epithelial cell | 3 studies | 31% ± 5% | |
dendritic cell | 3 studies | 19% ± 1% | |
abnormal cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of EHMT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3240.88 | 1445 / 1445 | 100% | 29.60 | 183 / 183 |
ovary | 100% | 5237.36 | 180 / 180 | 100% | 55.65 | 430 / 430 |
prostate | 100% | 4708.64 | 245 / 245 | 100% | 25.58 | 501 / 502 |
breast | 100% | 3360.71 | 458 / 459 | 100% | 31.05 | 1118 / 1118 |
intestine | 100% | 3837.16 | 966 / 966 | 100% | 29.40 | 525 / 527 |
uterus | 100% | 6387.32 | 170 / 170 | 100% | 34.85 | 457 / 459 |
brain | 100% | 6834.01 | 2641 / 2642 | 100% | 43.10 | 702 / 705 |
skin | 100% | 3322.76 | 1808 / 1809 | 100% | 35.97 | 470 / 472 |
thymus | 100% | 3881.92 | 653 / 653 | 100% | 25.34 | 602 / 605 |
bladder | 100% | 4212.19 | 21 / 21 | 99% | 28.28 | 500 / 504 |
stomach | 100% | 2654.80 | 358 / 359 | 99% | 30.32 | 284 / 286 |
pancreas | 99% | 1713.74 | 324 / 328 | 98% | 19.33 | 175 / 178 |
lung | 98% | 2651.68 | 566 / 578 | 99% | 24.84 | 1141 / 1155 |
adrenal gland | 99% | 3242.07 | 255 / 258 | 92% | 15.27 | 212 / 230 |
kidney | 99% | 2650.85 | 88 / 89 | 92% | 15.22 | 825 / 901 |
liver | 85% | 1018.48 | 191 / 226 | 87% | 14.73 | 355 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 36.56 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.17 | 29 / 29 |
spleen | 100% | 4626.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.92 | 1 / 1 |
blood vessel | 100% | 3189.65 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2883.01 | 1202 / 1204 | 0% | 0 | 0 / 0 |
heart | 88% | 1223.32 | 758 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 1863.27 | 755 / 929 | 0% | 0 | 0 / 0 |
muscle | 75% | 871.11 | 599 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035265 | Biological process | organ growth |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0031399 | Biological process | regulation of protein modification process |
GO_0007130 | Biological process | synaptonemal complex assembly |
GO_0007616 | Biological process | long-term memory |
GO_0006346 | Biological process | DNA methylation-dependent heterochromatin formation |
GO_0048665 | Biological process | neuron fate specification |
GO_0044027 | Biological process | negative regulation of gene expression via chromosomal CpG island methylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0009267 | Biological process | cellular response to starvation |
GO_0045471 | Biological process | response to ethanol |
GO_0048599 | Biological process | oocyte development |
GO_0009566 | Biological process | fertilization |
GO_0071314 | Biological process | cellular response to cocaine |
GO_0060992 | Biological process | response to fungicide |
GO_1902902 | Biological process | negative regulation of autophagosome assembly |
GO_0018027 | Biological process | peptidyl-lysine dimethylation |
GO_0036166 | Biological process | phenotypic switching |
GO_0048148 | Biological process | behavioral response to cocaine |
GO_0006275 | Biological process | regulation of DNA replication |
GO_0007286 | Biological process | spermatid development |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0046974 | Molecular function | histone H3K9 methyltransferase activity |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0046976 | Molecular function | histone H3K27 methyltransferase activity |
GO_0140759 | Molecular function | histone H3K56 methyltransferase activity |
GO_0140947 | Molecular function | histone H3K9me2 methyltransferase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0016279 | Molecular function | protein-lysine N-methyltransferase activity |
GO_0002039 | Molecular function | p53 binding |
GO_0005515 | Molecular function | protein binding |
GO_0070742 | Molecular function | C2H2 zinc finger domain binding |
Gene name | EHMT2 |
Protein name | Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.367) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) Histone-lysine N-methyltransferase EHMT2 Euchromatic histone lysine methyltransferase 2 (Histone-lysine N-methyltransferase EHMT2) |
Synonyms | KMT1C NG36 BAT8 G9A C6orf30 |
Description | FUNCTION: Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also mediates monomethylation of 'Lys-56' of histone H3 (H3K56me1) in G1 phase, leading to promote interaction between histone H3 and PCNA and regulating DNA replication. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. May also methylate histone H1. In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53. Also methylates CDYL, WIZ, ACIN1, DNMT1, HDAC1, ERCC6, KLF12 and itself. Recruited to the promoters of target genes through interaction with transcriptional repressor MSX1, leading to the inhibition of myoblast differentiation via transcriptional repression of differentiation factors (By similarity). . |
Accessions | ENST00000629838.2 ENST00000448415.1 ENST00000451745.5 ENST00000424396.1 ENST00000420336.6 A2ABF9 ENST00000447162.1 ENST00000421926.6 ENST00000425250.6 Q96KQ7 ENST00000375528.8 ENST00000400008.7 ENST00000436403.6 H0Y4K5 A0A0G2JRN8 ENST00000458593.5 ENST00000427405.6 ENST00000436026.1 ENST00000454705.5 ENST00000383372.6 [Q96KQ7-2] ENST00000440987.5 ENST00000375537.9 [Q96KQ7-1] A0A0G2JRR0 ENST00000627114.2 ENST00000400006.7 A2ABF8 ENST00000450323.6 ENST00000420874.5 [Q96KQ7-2] ENST00000429506.6 [Q96KQ7-1] ENST00000443951.6 ENST00000446303.6 ENST00000450075.6 [Q96KQ7-1] ENST00000420930.2 ENST00000420623.1 A0A0G2JIS2 A0A0G2JK64 ENST00000375530.8 [Q96KQ7-2] ENST00000415323.6 ENST00000428442.6 ENST00000450229.5 [Q96KQ7-2] A0A0G2JIR1 ENST00000395728.7 ENST00000383373.8 [Q96KQ7-1] ENST00000419454.1 |